Episode # 186 • 27 Aug 2024
Blue Light Cystoscopy: Improving Bladder Cancer Detection
What is the role of blue light cystoscopy in bladder cancer? In this episode, Dr. Suzette Sutherland interviews Dr. Suzanne Merrill from Colorado Urology about the benefits of this technology in the diagnosis and treatment of bladder cancer, and how to implement it into your practice.
This podcast is supported by
Timestamps
00:00 - Introduction
03:45 - Epidemiology and Risk of Bladder Cancer
05:48 - AUA Guidelines for Bladder Cancer
08:01 - Mechanism and Benefits of Blue Light Cystoscopy
10:33 - Practical Applications
34:48 - Conclusion
Resources
You may also like
More about this episode
The doctors start by discussing the advantages of using blue light cystoscopy, including better detection rates of Ta and T1 lesions and the reduction of cancer recurrence by as much as 11%. They highlight the importance of complete transurethral resection of bladder tumor (TURBT) and patient compliance. Dr. Merrill emphasizes the necessity of accurate risk stratification and the logistics of real-life incorporation. Finally, she also comments on new bladder cancer technologies, such as narrow band imaging.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.